Altimmune Commercial Paper Liability (Quarterly) Insights

Altimmune, Inc. (ALT)

4.52 +0.14 (+3.20%) USD | NASDAQ | Feb 23, 16:00

4.54 +0.02 (+0.44%) Pre-Market: 08:27

View Commercial Paper Liability (Quarterly) for ALT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Commercial Paper Liability (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Commercial Paper Liability (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Commercial Paper Liability (Quarterly) Benchmarks

Start Trial

CorMedix, Inc.	--
Actinium Pharmaceuticals, Inc.	--
Aldeyra Therapeutics, Inc.	--
Viking Therapeutics, Inc.	--
Seres Therapeutics, Inc.	--